GALILEA MORALES: Open Payments
NPI 1407588874 · LAREDO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$567 in 20 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $17 · 2025 $567
Food & beverage: $567
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $332 |
| Sumitomo Pharma America, Inc. | 4 | $81 |
| Lundbeck LLC | 3 | $52 |
| Lilly USA, LLC | 2 | $30 |
| Agios Pharmaceuticals, Inc. | 1 | $21 |
| SANOFI PASTEUR INC. | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Amgen Inc. | 1 | $14 |
Products named: FARXIGA, AIRSUPRA, GEMTESA, REXULTI, BREZTRI, PYRUKYND, MENQUADFI, ZEPBOUND.
Industry payments across TX — which companies pay providers there.
